Symptomatic treatment and management of multiple sclerosis

Abraham, 2002, Laryngopharyngeal dysmotility in multiple sclerosis, Dysphagia, 17, 69, 10.1007/s00455-001-0103-7 Abraham, 1997, Neurologic impairment and disability status in outpatients with multiple sclerosis reporting dysphagia symptomatology, Neurorehabil Neural Repair, 11, 7, 10.1177/154596839701100102 Achiron, 2012, Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis, Brain Struct Funct, 218, 943, 10.1007/s00429-012-0440-3 Aisen, 1991, Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury, Arch Neurol, 48, 513, 10.1001/archneur.1991.00530170077023 Al-Araji, 2005, Reappraisal of Lhermitte's sign in multiple sclerosis, Mult Scler, 11, 398, 10.1191/1352458505ms1177oa Albright, 2003, Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin, J Neurosurg, 98, 291, 10.3171/jns.2003.98.2.0291 Allen, 1998, Teaching memory strategies to persons with multiple sclerosis, J Rehabil Res Dev, 35, 405 Alpini, 2001, Vertigo and multiple sclerosis: aspects of differential diagnosis, Neurol Sci, 22, S84, 10.1007/s100720100041 Al-Smadi, 2003, A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis, Clin Rehabil, 17, 742, 10.1191/0269215503cr672oa Altintas, 2007, Pulmonary function in multiple sclerosis without any respiratory complaints, Clin Neurol Neurosurg, 109, 242, 10.1016/j.clineuro.2006.09.004 Alusi, 2001, Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study 1, Brain, 124, 1576, 10.1093/brain/124.8.1576 Alusi, 2001, A study of tremor in multiple sclerosis, Brain, 124, 720, 10.1093/brain/124.4.720 Amarenco, 2003, Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder, J Urol, 169, 2210, 10.1097/01.ju.0000067446.17576.bd Amato, 2001, Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years, Arch Neurol, 58, 1602, 10.1001/archneur.58.10.1602 Amato, 2008, Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis, Neurology, 71, 632, 10.1212/01.wnl.0000324621.58447.00 Amend, 2008, Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects, Eur Urol, 53, 1021, 10.1016/j.eururo.2008.01.007 Archibald, 1994, Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients, Pain, 58, 89, 10.1016/0304-3959(94)90188-0 Au Duong, 2005, Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis, Neuroimage, 24, 533, 10.1016/j.neuroimage.2004.08.038 Audoin, 2003, Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS, Hum Brain Mapp, 20, 51, 10.1002/hbm.10128 Audoin, 2005, Functional MRI study of PASAT in normal subjects, MAGMA, 18, 96, 10.1007/s10334-004-0098-9 Audoin, 2008, Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study, Mult Scler, 14, 786, 10.1177/1352458508089360 Averbuch-Heller, 1995, Investigations of the pathogenesis of acquired pendular nystagmus, Brain, 118, 369, 10.1093/brain/118.2.369 Averbuch-Heller, 1997, A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus, Ann Neurol, 41, 818, 10.1002/ana.410410620 Ayache, 2009, Thalamic stimulation restores defective cerebellocortical inhibition in multiple sclerosis tremor, Mov Disord, 24, 467, 10.1002/mds.22416 Baker, 2008, The endocannabinoid system and multiple sclerosis, Curr Pharm Des, 14, 2326, 10.2174/138161208785740036 Baker, 2000, Cannabinoids control spasticity and tremor in a multiple sclerosis model, Nature, 404, 84, 10.1038/35003583 Bakshi, 2000, Brain MRI lesions and atrophy are related to depression in multiple sclerosis, Neuroreport, 11, 1153, 10.1097/00001756-200004270-00003 Bakshi, 2000, Fatigue in multiple sclerosis and its relationship to depression and neurologic disability, Mult Scler, 6, 181, 10.1177/135245850000600308 Ball, 2005, Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline, J Clin Psychiatry, 66, 94, 10.4088/JCP.v66n0113 Baloh, 1998, Vertigo, Lancet, 352, 1841, 10.1016/S0140-6736(98)05430-0 Bandelow, 2008, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision, World J Biol Psychiatry, 9, 248, 10.1080/15622970802465807 Bandini, 2001, Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis?, J Neurol Neurosurg Psychiatry, 71, 107, 10.1136/jnnp.71.1.107 Barak, 2002, Effect of interferon-beta-1b on cognitive functions in multiple sclerosis, Eur Neurol, 47, 11, 10.1159/000047940 Barak, 1999, Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial, J Neuropsychiatry Clin Neurosci, 11, 271, 10.1176/jnp.11.2.271 Barton, 1993, Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy, J Neurol Neurosurg Psychiatry, 56, 262, 10.1136/jnnp.56.3.262 Barton, 1994, Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs, Ann Neurol, 35, 319, 10.1002/ana.410350312 Barton, 1999, Acquired convergence-evoked pendular nystagmus in multiple sclerosis, J Neuroophthalmol, 19, 34, 10.1097/00041327-199903000-00008 Basso, 2006, Self-generated learning in people with multiple sclerosis, J Int Neuropsychol Soc, 12, 640, 10.1017/S1355617706060759 Basso, 2007, Self-generated learning in people with multiple sclerosis: an extension of Chiaravalloti and DeLuca (2002), J Clin Exp Neuropsychol, 1 Beard, 2003, Treatments for spasticity and pain in multiple sclerosis: a systematic review, Health Technol Assess, 7, iii, 10.3310/hta7400 Beck, 1998, Optic neuritis, 599 Becker, 2000, Continuous intrathecal baclofen infusion in the management of central deafferentation pain, J Pain Symptom Manage, 20, 313, 10.1016/S0885-3924(00)00214-1 Beiske, 2004, Pain and sensory complaints in multiple sclerosis, Eur J Neurol, 11, 479, 10.1111/j.1468-1331.2004.00815.x Beiske, 2008, Depression and anxiety amongst multiple sclerosis patients, Eur J Neurol, 15, 239, 10.1111/j.1468-1331.2007.02041.x Ben, 2006, Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients, Mult Scler, 12, 101, 10.1191/1352458506ms1232sr Benedict, 2002, Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis, J Neuropsychiatry Clin Neurosci, 14, 44, 10.1176/appi.neuropsych.14.1.44 Benedict, 2002, Minimal neuropsychological assessment of MS patients: a consensus approach, Clin Neuropsychol, 16, 381, 10.1076/clin.16.3.381.13859 Benedict, 2003, Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis, Mult Scler, 9, 393, 10.1191/1352458503ms902oa Benedict, 2004, Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis, J Neuroimaging, 14, 36S, 10.1111/j.1552-6569.2004.tb00277.x Benedict, 2005, Regional lobar atrophy predicts memory impairment in multiple sclerosis, AJNR Am J Neuroradiol, 26, 1824 Benedict, 2006, Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis, Arch Neurol, 63, 1301, 10.1001/archneur.63.9.1301 Benedict, 2006, Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS), J Int Neuropsychol Soc, 12, 549, 10.1017/S1355617706060723 Benedict, 2007, Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis, Mult Scler, 13, 722, 10.1177/1352458507075592 Bensmail, 2006, Aseptic meningitis after intrathecal baclofen injection, Spinal Cord, 44, 330, 10.1038/sj.sc.3101838 Bensmail, 2006, Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity, Neurology, 67, 1432, 10.1212/01.wnl.0000239827.38036.23 Berg, 2000, The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis, Arch Neurol, 57, 1289, 10.1001/archneur.57.9.1289 Berg, 2000, Lesion pattern in patients with multiple sclerosis and depression, Mult Scler, 6, 156, 10.1177/135245850000600304 Bergendal, 2007, Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study, Eur Neurol, 57, 193, 10.1159/000099158 Berk, 2003, The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy, Can J Neurol Sci, 30, 220, 10.1017/S0317167100002626 Bermel, 2002, Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis, Arch Neurol, 59, 275, 10.1001/archneur.59.2.275 Bertholon, 2006, Prospective study of positional nystagmus in 100 consecutive patients, Ann Otol Rhinol Laryngol, 115, 587, 10.1177/000348940611500804 Betts, 1993, Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis, J Neurol Neurosurg Psychiatry, 56, 245, 10.1136/jnnp.56.3.245 Betts, 1994, Erectile dysfunction in multiple sclerosis Associated neurological and neurophysiological deficits, and treatment of the condition, Brain, 117, 1303, 10.1093/brain/117.6.1303 Bever, 1994, The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial, Neurology, 44, 1054, 10.1212/WNL.44.6.1054 Beydoun, 2000, Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials, Pharmacotherapy, 20, 152S, 10.1592/phco.20.12.152S.35254 Bhidayasiri, 2000, A hypothetical scheme for the brainstem control of vertical gaze, Neurology, 54, 1985, 10.1212/WNL.54.10.1985 Bittar, 2005, Thalamotomy versus thalamic stimulation for multiple sclerosis tremor, J Clin Neurosci, 12, 638, 10.1016/j.jocn.2004.09.008 Bittar, 2005, Deep brain stimulation for pain relief: a meta-analysis, J Clin Neurosci, 12, 515, 10.1016/j.jocn.2004.10.005 Blaney, 2009, The impact of fatigue on communication in multiple sclerosis. The insider's perspective, Disabil Rehabil, 31, 170, 10.1080/09638280701869629 Blumel, 2008, Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction, Gynecol Endocrinol, 24, 691, 10.1080/09513590802454919 Bonavita, 2011, Distributed changes in default-mode resting-state connectivity in multiple sclerosis, Mult Scler, 17, 411, 10.1177/1352458510394609 Boneschi, 2008, Lifetime and actual prevalence of pain and headache in multiple sclerosis, Mult Scler, 14, 514, 10.1177/1352458507085551 Bonzano, 2009, Structural connectivity influences brain activation during PVSAT in multiple sclerosis, Neuroimage, 44, 9, 10.1016/j.neuroimage.2008.08.015 Bosma, 2005, Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis, Acta Neurol Scand, 112, 1, 10.1111/j.1600-0404.2005.00431.x Boviatsis, 2005, Functional outcome of intrathecal baclofen administration for severe spasticity, Clin Neurol Neurosurg, 107, 289, 10.1016/j.clineuro.2004.09.007 Bowen, 2000, MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis, AJNR Am J Neuroradiol, 21, 647 Bozek, 1987, A controlled trial of isoniazid therapy for action tremor in multiple sclerosis, J Neurol, 234, 36, 10.1007/BF00314007 Brandt, 1990, Positional and positioning vertigo and nystagmus, J Neurol Sci, 95, 3, 10.1016/0022-510X(90)90113-2 Brass, 2006, Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis, Mult Scler, 12, 437, 10.1191/135248506ms1301oa Brenk, 2008, Short-term cognitive training improves mental efficiency and mood in patients with multiple sclerosis, Eur Neurol, 60, 304, 10.1159/000157885 Breuer, 2007, A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis, Clin Ther, 29, 2022, 10.1016/j.clinthera.2007.09.023 Brioschi, 2009, Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients, Eur Neurol, 62, 243, 10.1159/000232927 Brisman, 1987, Trigeminal neuralgia and multiple sclerosis, Arch Neurol, 44, 379, 10.1001/archneur.1987.00520160021008 Brissart, 2009, Cognitive rehabilitation in multiple sclerosis: preliminary results and presentation of a new program, PROCOG-SEP, Rev Neurol (Paris) Brochet, 2009, Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study, Clin J Pain, 25, 211, 10.1097/AJP.0b013e3181891347 Broggi, 1999, Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis, Lancet, 354, 1878, 10.1016/S0140-6736(99)94422-7 Broggi, 2000, Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 68, 59, 10.1136/jnnp.68.1.59 Broggi, 2004, Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis, Neurosurgery, 55, 830, 10.1227/01.NEU.0000137656.59536.0E Brooks, 2004, Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial, Neurology, 63, 1364, 10.1212/01.WNL.0000142042.50528.2F Brown, 2009, Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction, Ann Pharmacother, 43, 1275, 10.1345/aph.1L691 Brown, 2009, Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis, Psychol Psychother, 82, 41, 10.1348/147608308X345614 Buchel, 2004, White matter asymmetry in the human brain: a diffusion tensor MRI study, Cereb Cortex, 14, 945, 10.1093/cercor/bhh055 Buyse, 1997, Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients, Eur Respir J, 10, 139, 10.1183/09031936.97.10010139 Cader, 2006, Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis, Brain, 129, 527, 10.1093/brain/awh670 Cader, 2009, Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis, J Psychopharmacol, 23, 686, 10.1177/0269881108093271 Calabrese, 2009, Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis, Arch Neurol, 66, 1144, 10.1001/archneurol.2009.174 Cameron, 1996, Assessment of the effect of increased dietary fibre intake on bowel function in patients with spinal cord injury, Spinal Cord, 34, 277, 10.1038/sc.1996.50 Camp, 1999, Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates, Brain, 122, 1341, 10.1093/brain/122.7.1341 Camp, 2005, A longitudinal study of cognition in primary progressive multiple sclerosis, Brain, 128, 2891, 10.1093/brain/awh602 Campbell, 1966, Clinical trial of carbazepine (tegretol) in trigeminal neuralgia, J Neurol Neurosurg Psychiatry, 29, 265, 10.1136/jnnp.29.3.265 Cardinal, 2008, A longitudinal fMRI study of the paced auditory serial addition task, Mult Scler, 14, 465, 10.1177/1352458507084263 Cardozo, 2008, Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial, BJU Int, 102, 1120, 10.1111/j.1464-410X.2008.07939.x Cerasa, 2006, Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis, Brain Res Bull, 69, 597, 10.1016/j.brainresbull.2005.11.006 Chahine, 2006, Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine, Epilepsy Behav, 8, 610, 10.1016/j.yebeh.2006.01.017 Chapple, 2005, A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder, BJU Int, 95, 993, 10.1111/j.1464-410X.2005.05454.x Chartier-Kastler, 2000, Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia, J Urol, 164, 1476, 10.1016/S0022-5347(05)67010-3 Cheng, 2005, Management of medically refractory trigeminal neuralgia in patients with multiple sclerosis, Neurosurg Focus, 18, e13, 10.3171/foc.2005.18.5.14 Chia, 1995, Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction, J Neurol, 242, 105, 10.1007/BF00887825 Chia, 1996, Paradoxical puborectalis contraction is a feature of constipation in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 60, 31, 10.1136/jnnp.60.1.31 Chiara, 2006, Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough, Arch Phys Med Rehabil, 87, 468, 10.1016/j.apmr.2005.12.035 Chiara, 2007, Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis, Neurorehabil Neural Repair, 21, 239, 10.1177/1545968306294737 Chiaravalloti, 2002, Self-generation as a means of maximizing learning in multiple sclerosis: an application of the generation effect, Arch Phys Med Rehabil, 83, 1070, 10.1053/apmr.2002.33729 Chiaravalloti, 2008, Cognitive impairment in multiple sclerosis, Lancet Neurol, 7, 1139, 10.1016/S1474-4422(08)70259-X Chiaravalloti, 2003, Can the repetition effect maximize learning in multiple sclerosis?, Clin Rehabil, 17, 58, 10.1191/0269215503cr586oa Chiaravalloti, 2005, Cerebral activation patterns during working memory performance in multiple sclerosis using FMRI, J Clin Exp Neuropsychol, 27, 33, 10.1080/138033990513609 Chiaravalloti, 2005, Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial, Mult Scler, 11, 58, 10.1191/1352458505ms1118oa Chiba, 1992, Amantadine treatment for refractory pain and fatigue in patients with multiple sclerosis, Can J Neurol Sci, 19, 309, 10.1017/S0317167100042360 Chiotakakou-Faliakou, 1998, Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation, Gut, 42, 517, 10.1136/gut.42.4.517 Chitsaz, 2009, Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation, Clin J Pain, 25, 281, 10.1097/AJP.0b013e318190862b Christodoulou, 2006, Effects of donepezil on memory and cognition in multiple sclerosis, J Neurol Sci, 245, 127, 10.1016/j.jns.2005.08.021 Cianchetti, 1999, Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations, Neurology, 53, 433, 10.1212/WNL.53.2.433 Clifford, 1984, Pain in multiple sclerosis, Arch Neurol, 41, 1270, 10.1001/archneur.1984.04050230052017 Cohen, 1989, Amantadine treatment of fatigue associated with multiple sclerosis, Arch Neurol, 46, 676, 10.1001/archneur.1989.00520420096030 Comi, 1993, Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis, J Neurol Sci, 115, S66, 10.1016/0022-510X(93)90212-H Comi, 1998, Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis, J Neurol Neurosurg Psychiatry, 64, S21 Conte, 2009, Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis, Eur J Pain, 13, 472, 10.1016/j.ejpain.2008.05.014 Cooper, 2006, Response of intrathecal baclofen resistance to dose reduction, Neurology, 67, 1495, 10.1212/01.wnl.0000240223.01418.2e Cordella, 2009, Hypothalamic stimulation for trigeminal neuralgia in multiple sclerosis patients: efficacy on the paroxysmal ophthalmic pain, Mult Scler, 15, 1322, 10.1177/1352458509107018 Cote, 2013, Impact of sleep disorder treatment on fatigue in multiple sclerosis, Mult Scler, 19, 480, 10.1177/1352458512455958 Cox, 2004, The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients, Mult Scler, 10, 626, 10.1191/1352458504ms1095oa Craven, 1998, A review of the outcome of stoma surgery on spinal cord injured patients, J Adv Nurs, 27, 922, 10.1046/j.1365-2648.1998.00582.x Cruccu, 2007, EFNS guidelines on neurostimulation therapy for neuropathic pain, Eur J Neurol, 14, 952, 10.1111/j.1468-1331.2007.01916.x Cruccu, 2008, AAN-EFNS guidelines on trigeminal neuralgia management, Eur J Neurol, 15, 1013, 10.1111/j.1468-1331.2008.02185.x Currie, 1986, The use of clonazepam in the treatment of nystagmus-induced oscillopsia, Ophthalmology, 93, 924, 10.1016/S0161-6420(86)33640-6 Curry, 1999, The MACE procedure: experience in the United Kingdom, J Pediatr Surg, 34, 338, 10.1016/S0022-3468(99)90204-X Cutter, 2000, Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial, Arch Phys Med Rehabil, 81, 164, 10.1016/S0003-9993(00)90135-7 Cvetkovic, 2005, Desmopressin: in adults with nocturia, Drugs, 65, 99, 10.2165/00003495-200565010-00008 Dahl, 2009, Anxiety and depression in multiple sclerosis A comparative population-based study in Nord-Trondelag County, Norway, Mult Scler, 15, 1495, 10.1177/1352458509351542 Dahm, 1998, Long-term intrathecal (i.t.) infusion of bupivacaine relieved intractable pain and spasticity in a patient with multiple sclerosis, Eur J Pain, 2, 81, 10.1016/S1090-3801(98)90049-0 D'Aleo, 2011, Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine, Neurol Sci, 32, 293, 10.1007/s10072-010-0364-8 Dall, 1996, Use of clonidine for treatment of spasticity arising from various forms of brain injury: a case series, Brain Inj, 10, 453 Dalton, 2008, The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis, Mult Scler, 14, 571, 10.1177/1352458507085552 DasGupta, 2003, Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies, Drugs, 63, 153, 10.2165/00003495-200363020-00003 Dasgupta, 1997, The 'Queen Square bladder stimulator': a device for assisting emptying of the neurogenic bladder, Br J Urol, 80, 234, 10.1046/j.1464-410X.1997.00227.x DasGupta, 2004, Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis, J Urol, 171, 1189, 10.1097/01.ju.0000113145.43174.24 Davidson, 2004, Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study, Depress Anxiety, 19, 234, 10.1002/da.10146 Davis, 2008, Testosterone for low libido in postmenopausal women not taking estrogen, N Engl J Med, 359, 2005, 10.1056/NEJMoa0707302 de Carvalho, 2012, A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis, Mult Scler, 18, 82, 10.1177/1352458511415748 de Paula, 2007, The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms, Maturitas, 56, 69, 10.1016/j.maturitas.2006.06.005 de Seze, 1998, Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions, Neurourol Urodyn, 17, 513, 10.1002/(SICI)1520-6777(1998)17:5<513::AID-NAU7>3.0.CO;2-G de Seze, 2011, Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study, Neurourol Urodyn, 30, 306, 10.1002/nau.20958 Deer, 2007, Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication, Pain Med, 8, 259, 10.1111/j.1526-4637.2006.00150.x Dell'Osso, 2000, Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis, Neurology, 54, 2190, 10.1212/WNL.54.11.2190-b Dell'Osso, 2010, Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy, Hum Psychopharmacol, 25, 17, 10.1002/hup.1074 DeLuca, 1998, Acquisition and storage deficits in multiple sclerosis, J Clin Exp Neuropsychol, 20, 376, 10.1076/jcen.20.3.376.819 Demaree, 2000, Learning impairment is associated with recall ability in multiple sclerosis, J Clin Exp Neuropsychol, 22, 865, 10.1076/jcen.22.6.865.961 Denney, 2005, Cognitive impairment in three subtypes of multiple sclerosis, Arch Clin Neuropsychol, 20, 967, 10.1016/j.acn.2005.04.012 Denney, 2008, A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters, J Neurol Sci, 267, 129, 10.1016/j.jns.2007.10.007 Depalo, 2003, Eight eye muscle surgical treatment in a patient with acquired nystagmus and strabismus: a case report, Binocul Vis Strabismus Q, 18, 151 Deville, 2004, The urine dipstick test useful to rule out infections A meta-analysis of the accuracy, BMC Urol, 4, 4, 10.1186/1471-2490-4-4 Di Legge, 2003, Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis, Mult Scler, 9, 302, 10.1191/1352458503ms921oa Di Rezze, 2012, Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study, Clin Neuropharmacol, 35, 231, 10.1097/WNF.0b013e3182613dce Dieterich, 1991, The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus, J Neurol Neurosurg Psychiatry, 54, 627, 10.1136/jnnp.54.7.627 Dineen, 2009, Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis, Brain, 132, 239, 10.1093/brain/awn275 DMKG Study Group, 2003, Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis, J Neurol, 250, 542, 10.1007/s00415-003-1032-1 Dolly, 2006, The structure and mode of action of different botulinum toxins, Eur J Neurol, 13, 1, 10.1111/j.1468-1331.2006.01648.x Douglas, 2008, Illness and demographic correlates of chronic pain among a community-based sample of people with multiple sclerosis, Arch Phys Med Rehabil, 89, 1923, 10.1016/j.apmr.2008.03.022 Drake, 2006, Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis, Neurol India, 54, 370, 10.4103/0028-3886.28108 Drew, 2008, Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study, Arch Clin Neuropsychol, 23, 1, 10.1016/j.acn.2007.09.005 Duquette, 1985, Isoniazid for tremor in multiple sclerosis: a controlled trial, Neurology, 35, 1772, 10.1212/WNL.35.12.1772 Duthie, 2007, Botulinum toxin injections for adults with overactive bladder syndrome, Cochrane Database Syst Rev, 10.1002/14651858.CD005493.pub2 Eckford, 1994, Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis, Br J Urol, 74, 733, 10.1111/j.1464-410X.1994.tb07116.x Edwards, 2004, A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic, Mult Scler, 10, 575, 10.1191/1352458504ms1087oa Ehren, 2007, Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study, Scand J Urol Nephrol, 41, 335, 10.1080/00365590601068835 Ekbom, 1971, Carbamazepine, a new symptomatic treatment for the paraesthesiae associated with Lhermitte's sign, Z Neurol, 200, 341 Eldridge, 2003, Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis, Stereotact Funct Neurosurg, 81, 57, 10.1159/000075105 Erwin, 2011, Intrathecal baclofen in multiple sclerosis: too little, too late?, Mult Scler, 17, 623, 10.1177/1352458510395056 Etzion, 2001, Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells, Exp Brain Res, 139, 419, 10.1007/s002210100788 Faaborg, 2009, Long-term outcome and safety of transanal colonic irrigation for neurogenic bowel dysfunction, Spinal Cord, 47, 545, 10.1038/sc.2008.159 Fader, 2007, Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial, J Urol, 177, 208, 10.1016/j.juro.2006.08.099 Falah, 2012, A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis, Eur J Pain, 16, 860, 10.1002/j.1532-2149.2011.00073.x Fassbender, 1998, Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation, Arch Neurol, 55, 66, 10.1001/archneur.55.1.66 Feinstein, 2007, Neuropsychiatric syndromes associated with multiple sclerosis, J Neurol, 254, II73 Feinstein, 1992, Psychotic illness in multiple sclerosis A clinical and magnetic resonance imaging study, Br J Psychiatry, 161, 680, 10.1192/bjp.161.5.680 Feinstein, 1997, Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis, Arch Neurol, 54, 1116, 10.1001/archneur.1997.00550210050012 Feinstein, 1999, Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex, Mult Scler, 5, 69, 10.1177/135245859900500201 Feinstein, 1999, The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis, Mult Scler, 5, 323, 10.1177/135245859900500504 Feinstein, 2002, Multiple sclerosis, interferon beta-1b and depression A prospective investigation, J Neurol, 249, 815, 10.1007/s00415-002-0725-0 Feinstein, 2004, Structural brain abnormalities in multiple sclerosis patients with major depression, Neurology, 62, 586, 10.1212/01.WNL.0000110316.12086.0C Feinstein, 2010, Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients, Mult Scler, 16, 189, 10.1177/1352458509355461 Feys, 2009, The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis, Mult Scler, 15, 371, 10.1177/1352458508099142 Fife, 2009, Benign paroxysmal positional vertigo, Semin Neurol, 29, 500, 10.1055/s-0029-1241041 Filippi, 2000, Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis, J Neurol Neurosurg Psychiatry, 68, 157, 10.1136/jnnp.68.2.157 Fischer, 2000, Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis Multiple Sclerosis Collaborative Research Group, Ann Neurol, 48, 885, 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1 Fjorback, 2006, Event driven electrical stimulation of the dorsal penile/clitoral nerve for management of neurogenic detrusor overactivity in multiple sclerosis, Neurourol Urodyn, 25, 349, 10.1002/nau.20170 Fjorback, 2007, Electrical stimulation of sacral dermatomes in multiple sclerosis patients with neurogenic detrusor overactivity, Neurourol Urodyn, 26, 525, 10.1002/nau.20363 Fjorback, 2007, Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS, Eur Urol, 51, 464, 10.1016/j.eururo.2006.07.024 Flax, 1991, Effect of fluoxetine on patients with multiple sclerosis, Am J Psychiatry, 148, 1603, 10.1176/ajp.148.11.1603a Flechter, 2007, Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study, Isr Med Assoc J, 9, 457 Foley, 2009, Redefining functionality and treatment efficacy in multiple sclerosis, Neurology, 72, S1, 10.1212/WNL.0b013e3181a99bc2 Foley, 1992, A prospective study of depression and immune dysregulation in multiple sclerosis, Arch Neurol, 49, 238, 10.1001/archneur.1992.00530270052018 Foong, 1999, Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology, J Neuropsychiatry Clin Neurosci, 11, 45, 10.1176/jnp.11.1.45 Formica, 2005, Gabapentin for spasticity: a randomized, double-blind, placebo-controlled trial, Med Clin (Barc), 124, 81, 10.1157/13070862 Forn, 2006, Cortical reorganization during PASAT task in MS patients with preserved working memory functions, Neuroimage, 31, 686, 10.1016/j.neuroimage.2005.12.030 Forn, 2012, Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study, Mult Scler, 18, 153, 10.1177/1352458511417744 Fowler, 2005, A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis, J Neurol Neurosurg Psychiatry, 76, 700, 10.1136/jnnp.2004.038695 Fowler, 2008, The neural control of micturition, Nat Rev Neurosci, 9, 453, 10.1038/nrn2401 Fowler, 2009, A UK consensus on the management of the bladder in multiple sclerosis, J Neurol Neurosurg Psychiatry, 80, 470 Fox, 2004, The effect of cannabis on tremor in patients with multiple sclerosis, Neurology, 62, 1105, 10.1212/01.WNL.0000118203.67138.3E Franklin, 1988, Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis, Neurology, 38, 1826, 10.1212/WNL.38.12.1826 Freeman, 2006, The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS), Int Urogynecol J Pelvic Floor Dysfunct, 17, 636, 10.1007/s00192-006-0086-x Freynhagen, 2009, Diagnosis and management of neuropathic pain, BMJ, 339, b3002, 10.1136/bmj.b3002 Frohman, 2000, Vertigo in MS: utility of positional and particle repositioning maneuvers, Neurology, 55, 1566, 10.1212/WNL.55.10.1566 Frohman, 2003, Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques, Mult Scler, 9, 250, 10.1191/1352458503ms901oa Fromm, 1987, Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia, Neurology, 37, 1725, 10.1212/WNL.37.11.1725 Fromm, 1984, Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up, Ann Neurol, 15, 240, 10.1002/ana.410150306 Fry, 2007, Randomized control trial of effects of a 10-week inspiratory muscle training program on measures of pulmonary function in persons with multiple sclerosis, J Neurol Phys Ther, 31, 162, 10.1097/NPT.0b013e31815ce136 Fukuhara, 2009, Tangled catheter as a rare cause of baclofen pump malfunction, Surg Neurol, 72, 80, 10.1016/j.surneu.2008.01.043 Fulton, 1999, MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis, AJNR Am J Neuroradiol, 20, 1951 Gajewski, 1986, Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia, J Urol, 135, 966, 10.1016/S0022-5347(17)45940-4 Galetta, 2002, Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review, Arch Intern Med, 162, 2161, 10.1001/archinte.162.19.2161 Game, 2008, Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections, Eur Urol, 53, 613, 10.1016/j.eururo.2007.08.039 Gaudino, 2001, A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis, Neuropsychiatry Neuropsychol Behav Neurol, 14, 32 Gbadamosi, 2001, Failure of ondansetron in treating cerebellar tremor in MS patients – an open-label pilot study 1, Acta Neurol Scand, 104, 308, 10.1034/j.1600-0404.2001.00075.x Geders, 1995, The effect of cisapride on segmental colonic transit time in patients with spinal cord injury, Am J Gastroenterol, 90, 285 Geisler, 1996, The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis, Arch Neurol, 53, 185, 10.1001/archneur.1996.00550020101021 Geny, 1996, Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation, Mov Disord, 11, 489, 10.1002/mds.870110503 Gerharz, 1997, The value of the MACE (Malone antegrade colonic enema) procedure in adult patients, J Am Coll Surg, 185, 544, 10.1016/S1072-7515(97)00125-7 Ghaffar, 2008, Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis, J Neurol, 255, 406, 10.1007/s00415-008-0685-1 Ghezzi, 1995, Erectile impotence in multiple sclerosis: a neurophysiological study, J Neurol, 242, 123, 10.1007/BF00936883 Gill, 1994, Defecography in multiple sclerosis patients with severe constipation, Radiology, 191, 553, 10.1148/radiology.191.2.8153339 Giovannelli, 2007, Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis, Clin Rehabil, 21, 331, 10.1177/0269215507072772 Glasauer, 2005, Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus, Ann N Y Acad Sci, 1039, 528, 10.1196/annals.1325.060 Goodman, 2007, Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study, Mult Scler, 13, 357, 10.1177/1352458506069538 Goodman, 2008, Dose comparison trial of sustained-release fampridine in multiple sclerosis, Neurology, 71, 1134, 10.1212/01.wnl.0000326213.89576.0e Goodman, 2009, Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial, Lancet, 373, 732, 10.1016/S0140-6736(09)60442-6 Gosselink, 2000, Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients, Arch Phys Med Rehabil, 81, 747, 10.1016/S0003-9993(00)90105-9 Goverover, 2008, Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances, Arch Phys Med Rehabil, 89, 1514, 10.1016/j.apmr.2007.11.059 Goverover, 2009, A functional application of the spacing effect to improve learning and memory in persons with multiple sclerosis, J Clin Exp Neuropsychol, 31, 513, 10.1080/13803390802287042 Greene, 2000, A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments, J Clin Psychopharmacol, 20, 350, 10.1097/00004714-200006000-00010 Groves, 1998, Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam, Adv Ther, 15, 241 Gruenwald, 2007, Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing, Mult Scler, 13, 95, 10.1177/1352458506071134 Guay, 2009, Cranberry and urinary tract infections, Drugs, 69, 775, 10.2165/00003495-200969070-00002 Guillotreau, 2011, Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction, Neurourol Urodyn, 30, 1503, 10.1002/nau.21121 Hadjimichael, 2007, Persistent pain and uncomfortable sensations in persons with multiple sclerosis, Pain, 127, 35, 10.1016/j.pain.2006.07.015 Hadjimichael, 2008, Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey, Health Qual Life Outcomes, 6, 100, 10.1186/1477-7525-6-100 Hagemann, 2003, Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction, Eur Urol, 43, 412, 10.1016/S0302-2838(03)00002-2 Haiman, 2009, Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect, J Clin Psychopharmacol, 29, 444, 10.1097/JCP.0b013e3181b5ae5c Haldeman, 1982, Colonometry, cystometry, and evoked potentials in multiple sclerosis, Arch Neurol, 39, 698, 10.1001/archneur.1982.00510230024008 Hallett, 1985, Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis, Neurology, 35, 1374, 10.1212/WNL.35.9.1374 Hamalainen, 2012, The effects of heat stress on cognition in persons with multiple sclerosis, Mult Scler, 18, 489, 10.1177/1352458511422926 Hardmeier, 2012, Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography, PLoS One, 7, e42087, 10.1371/journal.pone.0042087 Harries, 2011, Percutaneous glycerol rhizotomy for trigeminal neuralgia: safety and efficacy of repeat procedures, Br J Neurosurg, 25, 268, 10.3109/02688697.2011.558946 Hashim, 2008, How should patients with an overactive bladder manipulate their fluid intake?, BJU Int, 102, 62, 10.1111/j.1464-410X.2008.07463.x Hellwig, 2006, Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis, Scientific World J, 6, 460, 10.1100/tsw.2006.86 Helmchen, 2007, Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion, J Neurol, 254, 1126, 10.1007/s00415-006-0448-9 Hemmett, 2004, What drives quality of life in multiple sclerosis?, QJM, 97, 671, 10.1093/qjmed/hch105 Hennessey, 1999, Urinary, faecal and sexual dysfunction in patients with multiple sclerosis, J Neurol, 246, 1027, 10.1007/s004150050508 Herishanu, 1986, Trihexyphenidyl treatment of vertical pendular nystagmus, Neurology, 36, 82, 10.1212/WNL.36.1.82 Herman, 1992, Intrathecal baclofen suppresses central pain in patients with spinal lesions A pilot study, Clin J Pain, 8, 338, 10.1097/00002508-199212000-00008 Hess, 2008, Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder, Spinal Cord, 46, 622, 10.1038/sc.2008.25 Hilton, 1983, The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis, J Neurol Neurosurg Psychiatry, 46, 854, 10.1136/jnnp.46.9.854 Hinds, 1990, Prevalence of bowel dysfunction in multiple sclerosis A population survey, Gastroenterology, 98, 1538, 10.1016/0016-5085(90)91087-M Hirsch, 1994, Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction, Paraplegia, 32, 661, 10.1038/sc.1994.106 Hirsh, 2009, Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors, Arch Phys Med Rehabil, 90, 646, 10.1016/j.apmr.2008.10.019 Hohol, 1997, Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis, Arch Neurol, 54, 1018, 10.1001/archneur.1997.00550200074013 Hooge, 1995, Trigeminal neuralgia in multiple sclerosis, Neurology, 45, 1294, 10.1212/WNL.45.7.1294 Hosseini, 2012, Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis, Neurosurgery, 70, 66, 10.1227/NEU.0b013e31822da55c House, 1997, Pharmacologically initiated defecation for persons with spinal cord injury: effectiveness of three agents, Arch Phys Med Rehabil, 78, 1062, 10.1016/S0003-9993(97)90128-3 Houtchens, 1997, Open label gabapentin treatment for pain in multiple sclerosis, Mult Scler, 3, 250, 10.1177/135245859700300407 Houtchens, 2007, Thalamic atrophy and cognition in multiple sclerosis, Neurology, 69, 1213, 10.1212/01.wnl.0000276992.17011.b5 Hoverd, 1998, Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 65, 778, 10.1136/jnnp.65.5.778 Howard, 1992, Respiratory involvement in multiple sclerosis, Brain, 115, 479, 10.1093/brain/115.2.479 Hoyer, 2009, Psychotherapy for generalized anxiety disorder: don't worry, it works!, Psychiatr Clin North Am, 32, 629, 10.1016/j.psc.2009.05.002 Huang, 2002, Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients, Stereotact Funct Neurosurg, 79, 44, 10.1159/000069503 Huijbregts, 2004, Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS, Neurology, 63, 335, 10.1212/01.WNL.0000129828.03714.90 Hutchinson, 1993, Bipolar affective disorder prior to the onset of multiple sclerosis, Acta Neurol Scand, 88, 388, 10.1111/j.1600-0404.1993.tb05365.x Hyman, 2000, Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study, J Neurol Neurosurg Psychiatry, 68, 707, 10.1136/jnnp.68.6.707 Iaffaldano, 2012, Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study, PLoS One, 7, e35843, 10.1371/journal.pone.0035843 Indaco, 1994, Chronic and acute pain syndromes in patients with multiple sclerosis, Acta Neurol (Napoli), 16, 97 Iskedjian, 2007, Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain, Curr Med Res Opin, 23, 17, 10.1185/030079906X158066 Jabbari, 1987, Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction, Mov Disord, 2, 93, 10.1002/mds.870020202 Jain, 2002, Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis, Am J Ophthalmol, 134, 780, 10.1016/S0002-9394(02)01629-X Janssens, 2003, Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners, Acta Neurol Scand, 108, 389, 10.1034/j.1600-0404.2003.00166.x Janssens, 2006, Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study, Mult Scler, 12, 794, 10.1177/1352458506070935 Jarrett, 2002, Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?, J Neurol Neurosurg Psychiatry, 73, 705, 10.1136/jnnp.73.6.705 Jarrett, 2008, Sacral nerve stimulation for fecal incontinence related to obstetric anal sphincter damage, Dis Colon Rectum, 51, 531, 10.1007/s10350-008-9199-2 Jensen, 1982, Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features, Acta Neurol Scand, 65, 182, 10.1111/j.1600-0404.1982.tb03076.x Joffe, 1987, Mood disorder and multiple sclerosis, Arch Neurol, 44, 376, 10.1001/archneur.1987.00520160018007 Jones, 2012, A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register, PLoS One, 7, e41910, 10.1371/journal.pone.0041910 Jonsson, 1993, Effects of neuropsychological treatment in patients with multiple sclerosis, Acta Neurol Scand, 88, 394, 10.1111/j.1600-0404.1993.tb05366.x Jorns, 2007, Evidence-based approach to the medical management of trigeminal neuralgia, Br J Neurosurg, 21, 253, 10.1080/02688690701219175 Jorns, 2009, Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia, Eur J Neurol, 16, 740, 10.1111/j.1468-1331.2009.02585.x Julian, 2009, Relationships among anxiety, depression, and executive functioning in multiple sclerosis, Clin Neuropsychol, 23, 794, 10.1080/13854040802665808 Kabay, 2008, Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study, Urology, 71, 641, 10.1016/j.urology.2007.11.135 Kabay, 2009, The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction, Neurorurol Urodyn, 28, 964, 10.1002/nau.20733 Kabus, 2006, Botulinum toxin in patients with multiple sclerosis, J Neurol, 253, I26, 10.1007/s00415-006-1106-y Kalia, 2005, Severity of chronic pain and its relationship to quality of life in multiple sclerosis, Mult Scler, 11, 322, 10.1191/1352458505ms1168oa Kalla, 2004, 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain, Neurology, 62, 1228, 10.1212/01.WNL.0000118287.68294.E5 Kalla, 2007, 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus, Brain, 130, 2441, 10.1093/brain/awm172 Kalsi, 2007, Botulinum injections for the treatment of bladder symptoms of multiple sclerosis, Ann Neurol, 62, 452, 10.1002/ana.21209 Kamen, 2008, A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury, Curr Med Res Opin, 24, 425, 10.1185/030079908X261113 Kanchandani, 1982, Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature, J Neurol Neurosurg Psychiatry, 45, 308, 10.1136/jnnp.45.4.308 Kanpolat, 2000, Percutaneous controlled radiofrequency rhizotomy in the management of patients with trigeminal neuralgia due to multiple sclerosis, Acta Neurochir (Wien), 142, 685, 10.1007/s007010070113 Karatas, 2008, Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes, Neurologist, 14, 355, 10.1097/NRL.0b013e31817533a3 Karatas, 2009, Internuclear and supranuclear disorders of eye movements: clinical features and causes, Eur J Neurol, 16, 1265, 10.1111/j.1468-1331.2009.02779.x Katusic, 1990, Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984, Ann Neurol, 27, 89, 10.1002/ana.410270114 Kehler, 2009, Is health anxiety a significant problem for individuals with multiple sclerosis?, J Behav Med, 32, 150, 10.1007/s10865-008-9186-z Khalil, 2011, Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome, Mult Scler, 17, 173, 10.1177/1352458510384009 Khan, 1998, Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients, Neurology, 51, 611, 10.1212/WNL.51.2.611 Khan, 2007, Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort, J Pain, 8, 614, 10.1016/j.jpain.2007.03.005 Khan, 2010, Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study, NeuroRehabilitation, 27, 117, 10.3233/NRE-2010-0587 Kheder, 2012, Spasticity: pathophysiology, evaluation and management, Pract Neurol, 12, 289, 10.1136/practneurol-2011-000155 Killian, 1968, Carbamazepine in the treatment of neuralgia Use of side-effects, Arch Neurol, 19, 129, 10.1001/archneur.1968.00480020015001 Kim, 2003, Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial, J Spinal Cord Med, 26, 358, 10.1080/10790268.2003.11753706 Kim, 2005, Mirtazapine treatment for pathological laughing and crying after stroke, Clin Neuropharmacol, 28, 249, 10.1097/01.wnf.0000185825.34819.ba Kinn, 1990, Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis, Scand J Urol Nephrol, 24, 109, 10.3109/00365599009180373 Kirkeby, 1988, Erectile dysfunction in multiple sclerosis, Neurology, 38, 1366, 10.1212/WNL.38.9.1366 Kitzman, 2007, Gabapentin suppresses spasticity in the spinal cord-injured rat, Neuroscience, 149, 813, 10.1016/j.neuroscience.2007.07.020 Klefbeck, 2003, Effect of inspiratory muscle training in patients with multiple sclerosis, Arch Phys Med Rehabil, 84, 994, 10.1016/S0003-9993(03)00133-3 Koch, 2007, Tremor in multiple sclerosis, J Neurol, 254, 133, 10.1007/s00415-006-0296-7 Koch, 2008, Fatigue, depression and progression in multiple sclerosis, Mult Scler, 14, 815, 10.1177/1352458508088937 Kohler, 1988, Multiple sclerosis presenting as chronic atypical psychosis, J Neurol Neurosurg Psychiatry, 51, 281, 10.1136/jnnp.51.2.281 Koller, 1984, Pharmacologic trials in the treatment of cerebellar tremor, Arch Neurol, 41, 280, 10.1001/archneur.1984.04050150058017 Korostil, 2007, Anxiety disorders and their clinical correlates in multiple sclerosis patients, Mult Scler, 13, 67, 10.1177/1352458506071161 Krevsky, 1989, Cisapride accelerates colonic transit in constipated patients with colonic inertia, Am J Gastroenterol, 84, 882 Krogh, 1998, Malone antegrade continence enema for faecal incontinence and constipation in adults, Br J Surg, 85, 974, 10.1046/j.1365-2168.1998.00772.x Krupp, 1988, Fatigue in multiple sclerosis, Arch Neurol, 45, 435, 10.1001/archneur.1988.00520280085020 Krupp, 1995, Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo [see comments], Neurology, 45, 1956, 10.1212/WNL.45.11.1956 Krupp, 2004, Donepezil improved memory in multiple sclerosis in a randomized clinical trial, Neurology, 63, 1579, 10.1212/01.WNL.0000142989.09633.5A Kujala, 1997, The progress of cognitive decline in multiple sclerosis A controlled 3-year follow-up, Brain, 120, 289, 10.1093/brain/120.2.289 Kumar, 2006, Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience, Neurosurgery, 58, 481, 10.1227/01.NEU.0000192162.99567.96 Lange, 2009, Modafinil effects in multiple sclerosis patients with fatigue, J Neurol, 256, 645, 10.1007/s00415-009-0152-7 Lapierre, 2007, Treating fatigue, Int MS J, 14, 64 Lavin, 1983, Downbeat nystagmus with a pseudocycloid waveform: improvement with base-out prisms, Ann Neurol, 13, 621, 10.1002/ana.410130607 Lazeron, 2000, Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR, Mult Scler, 6, 280, 10.1177/135245850000600410 Lazeron, 2004, An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis, Mult Scler, 10, 549, 10.1191/1352458504ms1072oa Lazeron, 2006, Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction, Mult Scler, 12, 760, 10.1177/1352458506070924 Lebrun, 2006, Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue, Mult Scler, 12, 321, 10.1191/135248506ms1275oa Legrand, 2011, Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experience, Urology, 78, 937, 10.1016/j.urology.2011.06.015 Leigh, 1991, Effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride, Neurology, 41, 1737, 10.1212/WNL.41.11.1737 Leigh, 1992, Effectiveness of botulinum toxin administered to abolish acquired nystagmus, Ann Neurol, 32, 633, 10.1002/ana.410320506 Lekka, 2006, Successful treatment with intradetrusor Botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters, Eur Urol, 50, 806, 10.1016/j.eururo.2005.12.015 Liebel, 2001, Oxcarbazepine in der Behandlung der Trigeminusneuralgie, Nervenheilkunde, 20, 461 Lilius, 1976, Sexual problems in patients suffering from multiple sclerosis, Scand J Soc Med, 4, 41, 10.1177/140349487600400108 Lincoln, 2002, Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis, J Neurol Neurosurg Psychiatry, 72, 93, 10.1136/jnnp.72.1.93 Loitfelder, 2011, Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI, Neurology, 76, 526, 10.1212/WNL.0b013e31820b75cf Lombardi, 2010, Efficacy and Safety of Tadalafil for Erectile Dysfunction in Patients with Multiple Sclerosis, J Sex Med, 7, 2192, 10.1111/j.1743-6109.2010.01797.x Longo, 1995, Cisapride for constipation in spinal cord injured patients: a preliminary report, J Spinal Cord Med, 18, 240, 10.1080/10790268.1995.11719403 Lopez, 1996, Clinical and MRI correlates in 27 patients with acquired pendular nystagmus, Brain, 119, 465, 10.1093/brain/119.2.465 Love, 2001, Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens, Neuropathol Appl Neurobiol, 27, 238, 10.1046/j.0305-1846.2001.00318.x Lovera, 2007, Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial, Mult Scler, 13, 376, 10.1177/1352458506071213 Lovera, 2012, Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial, Neurology, 79, 1278, 10.1212/WNL.0b013e31826aac60 Lunardi, 1997, Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia [see comments], Neurology, 48, 1714, 10.1212/WNL.48.6.1714 MacDonald, 2008, Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects, J Spinal Cord Med, 31, 157, 10.1080/10790268.2008.11760706 Mackenzie, 2009, Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis, Int J Lang Commun Disord, 44, 401, 10.1080/13682820802697879 Mailis, 2003, Sympathectomy for neuropathic pain, Cochrane Database Syst Rev Mainero, 2004, fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis, Neuroimage, 21, 858, 10.1016/j.neuroimage.2003.10.004 Mainero, 2004, Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine, Neurology, 62, 2044, 10.1212/01.WNL.0000129263.14219.A8 Mallory, 2012, Outcomes after percutaneous surgery for patients with multiple sclerosis-related trigeminal neuralgia, Neurosurgery, 71, 581, 10.1227/NEU.0b013e31825e795b Manzoni, 2005, Epidemiology of typical and atypical craniofacial neuralgias, Neurol Sci, 26, s65, 10.1007/s10072-005-0410-0 Marrie, 2007, Disparities in the management of multiple sclerosis-related bladder symptoms, Neurology, 68, 1971, 10.1212/01.wnl.0000264416.53077.8b Marti, 2005, The origin of downbeat nystagmus: an asymmetry in the distribution of on-directions of vertical gaze-velocity Purkinje cells, Ann N Y Acad Sci, 1039, 548, 10.1196/annals.1325.065 Masucci, 1988, Downbeat nystagmus secondary to multiple sclerosis, Ann Ophthalmol, 20, 347 Mathiesen, 2006, Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis, Arch Neurol, 63, 533, 10.1001/archneur.63.4.533 Mathieu, 2007, Gamma knife thalamotomy for multiple sclerosis tremor, Surg Neurol, 68, 394, 10.1016/j.surneu.2006.11.049 Mattioli, 2010, Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis, J Neurol Sci, 288, 101, 10.1016/j.jns.2009.09.024 McCarthy, 2005, Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis, Arch Clin Neuropsychol, 20, 705, 10.1016/j.acn.2005.04.007 McCleane, 1998, Lamotrigine can reduce neurogenic pain associated with multiple sclerosis, Clin J Pain, 14, 269, 10.1097/00002508-199809000-00015 McClurg, 2008, Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis–a double blind, placebo controlled, randomised clinical trial, Neurourol Urodyn, 27, 231, 10.1002/nau.20486 Mesaros, 2009, Corpus callosum damage and cognitive dysfunction in benign MS, Hum Brain Mapp, 30, 2656, 10.1002/hbm.20692 Metz, 2004, The effect of immunomodulatory treatment on multiple sclerosis fatigue, J Neurol Neurosurg Psychiatry, 75, 1045, 10.1136/jnnp.2002.007724 Milanov, 1992, Mechanisms of baclofen action on spasticity, Acta Neurol Scand, 85, 305, 10.1111/j.1600-0404.1992.tb04048.x Milanov, 1994, Mechanisms of tizanidine action on spasticity, Acta Neurol Scand, 89, 274, 10.1111/j.1600-0404.1994.tb01680.x Mills, 2007, Treatment for ataxia in multiple sclerosis, Cochrane Database Syst Rev, 10.1002/14651858.CD005029.pub2 Mohr, 1999, Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis, Arch Neurol, 56, 1263, 10.1001/archneur.56.10.1263 Mohr, 2001, Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis, J Consult Clin Psychol, 69, 942, 10.1037/0022-006X.69.6.942 Mohr, 2001, Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis, Arch Neurol, 58, 1081, 10.1001/archneur.58.7.1081 Monaca-Charley, 2003, Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis, J Neurol, 250, 1190, 10.1007/s00415-003-0176-3 Monaco, 1980, Psychotic onset of multiple sclerosis, Ital J Neurol Sci, 1, 279, 10.1007/BF02336711 Montano, 2013, What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures, Clin Neurol Neurosurg, 115, 567, 10.1016/j.clineuro.2012.07.011 Morgan, 2004, Botulinum toxin treatment of painful tonic spasms in multiple sclerosis, Neurology, 62, 2143, 10.1212/WNL.62.11.2143 Morrow, 2009, The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial, J Neurol, 256, 1095, 10.1007/s00415-009-5074-x Morrow, 2009, Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis, Mult Scler, 15, 998, 10.1177/1352458509106213 Morrow, 2013, Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study, J Neurol, 260, 489, 10.1007/s00415-012-6663-7 Mueller, 1997, Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis, Arch Phys Med Rehabil, 78, 521, 10.1016/S0003-9993(97)90168-4 Mukand, 1996, Pathological crying and laughing: treatment with sertraline, Arch Phys Med Rehabil, 77, 1309, 10.1016/S0003-9993(96)90198-7 Muller, 1999, Paroxetine versus citalopram treatment of pathological crying after brain injury, Brain Inj, 13, 805, 10.1080/026990599121197 Muller-Lissner, 1988, Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis, Br Med J (Clin Res Ed), 296, 615, 10.1136/bmj.296.6622.615 Murray, 1985, Amantadine therapy for fatigue in multiple sclerosis, Can J Neurol Sci, 12, 251, 10.1017/S0317167100047107 Mutluay, 2005, Effects of multiple sclerosis on respiratory functions, Clin Rehabil, 19, 426, 10.1191/0269215505cr782oa Naderi, 2012, The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis, Clin Neuropharmacol, 35, 224, 10.1097/WNF.0b013e31826249bb Nahas, 1998, Rapid response of emotional incontinence to selective serotonin reuptake inhibitors, J Neuropsychiatry Clin Neurosci, 10, 453, 10.1176/jnp.10.4.453 Nance, 1997, Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis, Arch Neurol, 54, 731, 10.1001/archneur.1997.00550180049011 Nandi, 2004, Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor, J Clin Neurophysiol, 21, 31, 10.1097/00004691-200401000-00005 Nelson, 2011, Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis, Mult Scler, 17, 1122, 10.1177/1352458511405561 Newland, 2008, Pain in women with relapsing-remitting multiple sclerosis and in healthy women: a comparative study, J Neurosci Nurs, 40, 262, 10.1097/01376517-200810000-00003 Nicholas, 2009, Anticholinergics for urinary symptoms in multiple sclerosis, Cochrane Database Syst Rev, 10.1002/14651858.CD004193.pub2 Nicol, 1969, A four year double-blind study of tegretol in facial pain, Headache, 9, 54, 10.1111/j.1526-4610.1969.hed0901054.x Nielsen, 2004, Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump, Mult Scler, 10, 521, 10.1191/1352458504ms1092oa Niranjan, 2000, Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor, Neurology, 55, 443, 10.1212/WNL.55.3.443 Nordenbo, 1996, Disturbances of ano-rectal function in multiple sclerosis, J Neurol, 243, 445, 10.1007/BF00900497 Norton, 2001, Anal plug for faecal incontinence, Colorectal Dis, 3, 323, 10.1046/j.1463-1318.2001.00257.x Novotna, 2011, A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis, Eur J Neurol, 18, 1122, 10.1111/j.1468-1331.2010.03328.x O'Brien, 2007, An investigation of the differential effect of self-generation to improve learning and memory in multiple sclerosis and traumatic brain injury, Neuropsychol Rehabil, 17, 273, 10.1080/09602010600751160 O'Brien, 2008, Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature, Arch Phys Med Rehabil, 89, 761, 10.1016/j.apmr.2007.10.019 O'Connor, 2008, Pain associated with multiple sclerosis: systematic review and proposed classification, Pain, 137, 96, 10.1016/j.pain.2007.08.024 Okuda, 2009, Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures, Brain, 132, 250, 10.1093/brain/awn301 O'Riordan, 1995, Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?, J Urol, 153, 1114, 10.1016/S0022-5347(01)67524-4 Osterberg, 2005, Central pain in multiple sclerosis – prevalence and clinical characteristics, Eur J Pain, 9, 531, 10.1016/j.ejpain.2004.11.005 Padma-Nathan, 1997, Treatment of men with erectile dysfunction with transurethral alprostadil Medicated Urethral System for Erection (MUSE) Study Group [see comments], N Engl J Med, 336, 1, 10.1056/NEJM199701023360101 Paice, 1996, Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases, Neurosurgery, 38, 203, 10.1097/00006123-199601000-00047 Paisley, 2002, Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review, Mult Scler, 8, 319, 10.1191/1352458502ms795rr Pan, 2001, Cognitive dysfunction lateralizes with NAA in multiple sclerosis, Appl Neuropsychol, 8, 155, 10.1207/S15324826AN0803_4 Panitch, 2006, Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis, Ann Neurol, 59, 780, 10.1002/ana.20828 Parry, 2003, Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine, Brain, 126, 2750, 10.1093/brain/awg284 Patten, 2003, Major depression in multiple sclerosis: a population-based perspective, Neurology, 61, 1524, 10.1212/01.WNL.0000095964.34294.B4 Patten, 2003, Depressive symptoms in a treated multiple sclerosis cohort, Mult Scler, 9, 616, 10.1191/1352458503ms960oa Patten, 2005, Psychotic disorders in MS: population-based evidence of an association, Neurology, 65, 1123, 10.1212/01.wnl.0000178998.95293.29 Patti, 2010, Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis, Mult Scler, 16, 68, 10.1177/1352458509350309 Pavan, 2007, Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis, Arq Neuropsiquiatr, 65, 332, 10.1590/S0004-282X2007000200027 Penn, 1987, Chronic intrathecal morphine for intractable pain, J Neurosurg, 67, 182, 10.3171/jns.1987.67.2.0182 Penner, 2003, Analysis of impairment related functional architecture in MS patients during performance of different attention tasks, J Neurol, 250, 461, 10.1007/s00415-003-1025-0 Penny, 2010, Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis, Neurology, 74, 545, 10.1212/WNL.0b013e3181cff6a6 Petajan, 1996, Impact of aerobic training on fitness and quality of life in multiple sclerosis, Ann Neurol, 39, 432, 10.1002/ana.410390405 Piatkowski, 2009, Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis: a randomized, double-blind controlled trial, J Altern Complement Med, 15, 507, 10.1089/acm.2008.0501 Pickett, 2005, Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis, Neurosurgery, 56, 537, 10.1227/01.NEU.0000153907.43563.FF Pierrot-Deseilligny, 2005, Vertical nystagmus: clinical facts and hypotheses, Brain, 128, 1237, 10.1093/brain/awh532 Pinder, 1977, Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity, Drugs, 13, 3, 10.2165/00003495-197713010-00002 Pine, 1995, Patients with multiple sclerosis presenting to psychiatric hospitals, J Clin Psychiatry, 56, 297 Piras, 2003, Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings, J Neurol Neurosurg Psychiatry, 74, 878, 10.1136/jnnp.74.7.878 Pittock, 2004, Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population, Mov Disord, 19, 1482, 10.1002/mds.20227 Plaha, 2008, Bilateral stimulation of the caudal zona incerta nucleus for tremor control, J Neurol Neurosurg Psychiatry, 79, 504, 10.1136/jnnp.2006.112334 Pliskin, 1996, Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b, Neurology, 47, 1463, 10.1212/WNL.47.6.1463 Plohmann, 1994, Evaluation of a computer-based attention retraining program for patients with multiple sclerosis, Schweiz Arch Neurol Psychiatr, 145, 35 Plohmann, 1998, Computer assisted retraining of attentional impairments in patients with multiple sclerosis, J Neurol Neurosurg Psychiatry, 64, 455, 10.1136/jnnp.64.4.455 Pollack, 2001, Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial, J Clin Psychiatry, 62, 350, 10.4088/JCP.v62n0508 Polman, 1994, 4-aminopyridine in the treatment of patients with multiple sclerosis Long-term efficacy and safety, Arch Neurol, 51, 292, 10.1001/archneur.1994.00540150090022 Potagas, 2008, Cognitive impairment in different MS subtypes and clinically isolated syndromes, J Neurol Sci, 267, 100, 10.1016/j.jns.2007.10.002 Prasad, 2003, Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study, Clin Rehabil, 17, 42, 10.1191/0269215503cr583oa Preziosi, 2009, Neurogenic bowel dysfunction: pathophysiology, clinical manifestations and treatment, Expert Rev Gastroenterol Hepatol, 3, 417, 10.1586/egh.09.31 Preziosi, 2011, Bowel biofeedback treatment in patients with multiple sclerosis and bowel symptoms, Dis Colon Rectum, 54, 1114, 10.1097/DCR.0b013e318223fd7b Preziosi, 2012, Transanal irrigation for bowel symptoms in patients with multiple sclerosis, Dis Colon Rectum, 55, 1066, 10.1097/DCR.0b013e3182653bd1 Pujol, 1997, Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis, Neurology, 49, 1105, 10.1212/WNL.49.4.1105 Rabins, 1986, Structural brain correlates of emotional disorder in multiple sclerosis, Brain, 109, 585, 10.1093/brain/109.4.585 Rachbauer, 2006, Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study, J Neurol Sci, 244, 11, 10.1016/j.jns.2005.11.035 Ramasubbu, 2003, Lamotrigine treatment for post-stroke pathological laughing and crying, Clin Neuropharmacol, 26, 233, 10.1097/00002826-200309000-00006 Rammohan, 2002, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, J Neurol Neurosurg Psychiatry, 72, 179, 10.1136/jnnp.72.2.179 Ranjeva, 2006, Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis, J Neurol Sci, 245, 161, 10.1016/j.jns.2005.09.019 Rao, 1989, Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis, Neurology, 39, 161, 10.1212/WNL.39.2.161 Rao, 1991, Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction, Neurology, 41, 685, 10.1212/WNL.41.5.685 Rao, 1993, Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding, and implicit learning, Neuropsychology, 7, 364, 10.1037/0894-4105.7.3.364 Rasche, 2004, Treatment of trigeminal neuralgia associated with multiple sclerosis: case report, Neurology, 63, 1714, 10.1212/01.WNL.0000142972.12040.44 Read, 1982, Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency, Dig Dis Sci, 27, 807, 10.1007/BF01391374 Reder, 1995, Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue, Neurology, 45, 1097, 10.1212/WNL.45.6.1097 Resnick, 1996, Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis, Surg Neurol, 46, 358, 10.1016/S0090-3019(96)00187-5 Restivo, 2003, Botulinum toxin treatment of painful tonic spasms in multiple sclerosis, Neurology, 61, 719, 10.1212/01.WNL.0000080081.74117.E4 Reynolds, 2011, Head pre-cooling improves symptoms of heat-sensitive multiple sclerosis patients, Can J Neurol Sci, 38, 106, 10.1017/S0317167100011136 Rice, 1997, Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor, J Neurol Neurosurg Psychiatry, 62, 282, 10.1136/jnnp.62.3.282 Ridley, 2006, Intrathecal baclofen therapy: challenges in patients with multiple sclerosis, Rehabil Nurs, 31, 158, 10.1002/j.2048-7940.2006.tb00381.x Ridley, 2006, Intrathecal baclofen therapy: ten steps toward best practice, J Neurosci Nurs, 38, 72, 10.1097/01376517-200604000-00002 Robinson, 1984, Alexander's law: its behavior and origin in the human vestibulo-ocular reflex, Ann Neurol, 16, 714, 10.1002/ana.410160614 Rocca, 2009, Structural and functional MRI correlates of Stroop control in benign MS, Hum Brain Mapp, 30, 276, 10.1002/hbm.20504 Rocca, 2010, Default-mode network dysfunction and cognitive impairment in progressive MS, Neurology, 74, 1252, 10.1212/WNL.0b013e3181d9ed91 Rockliff, 1966, Controlled sequential trials of carbamazepine in trigeminal neuralgia, Arch Neurol, 15, 129, 10.1001/archneur.1966.00470140019003 Rodgers, 1996, Cognitive therapy for multiple sclerosis: a preliminary study, Altern Ther Health Med, 2, 70 Rog, 2005, Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis, Neurology, 65, 812, 10.1212/01.wnl.0000176753.45410.8b Rog, 2007, Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial, Clin Ther, 29, 2068, 10.1016/j.clinthera.2007.09.013 Rogers, 2002, Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis, J Neurosurg, 97, 529, 10.3171/jns.2002.97.supplement_5.0529 Romberg, 2012, The effects of heat stress on physical functioning in persons with multiple sclerosis, J Neurol Sci, 319, 42, 10.1016/j.jns.2012.05.024 Ron, 1989, Psychiatric morbidity in multiple sclerosis: a clinical and MRI study, Psychol Med, 19, 887, 10.1017/S0033291700005602 Rosen, 2008, Dextromethorphan/quinidine sulfate for pseudobulbar affect, Drugs Today (Barc), 44, 661, 10.1358/dot.2008.44.9.1258664 Rosenberg, 1988, Amantadine, fatigue, and multiple sclerosis, Arch Neurol, 45, 1104, 10.1001/archneur.1988.00520340058012 Rosenhall, 1988, Positional nystagmus, Acta Otolaryngol Suppl, 455, 17, 10.3109/00016488809125051 Rossi, 2009, Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study, Eur J Neurol, 16, 360, 10.1111/j.1468-1331.2008.02496.x Rossini, 2001, Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine, Mult Scler, 7, 354, 10.1177/135245850100700602 Roussan, 1985, Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy, Pharmatherapeutica, 4, 278 Rovaris, 1998, Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis, Neurology, 50, 1601, 10.1212/WNL.50.6.1601 Rovaris, 2000, Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis, AJNR Am J Neuroradiol, 21, 402 Rovaris, 2002, Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging, J Neurol Sci, 195, 103, 10.1016/S0022-510X(01)00690-6 Rovaris, 2008, Cognitive impairment and structural brain damage in benign multiple sclerosis, Neurology, 71, 1521, 10.1212/01.wnl.0000319694.14251.95 Rucker, 2008, An update on acquired nystagmus, Semin Ophthalmol, 23, 91, 10.1080/08820530801888089 Ruud Bosch, 1996, Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients, Lancet, 348, 717, 10.1016/S0140-6736(96)04437-6 Sabra, 1982, Treatment of action tremor in multiple sclerosis with isoniazid, Neurology, 32, 912, 10.1212/WNL.32.8.912 Sadiq, 2007, Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity, J Neurol, 254, 1464, 10.1007/s00415-007-0566-z Sadovnick, 1991, Cause of death in patients attending multiple sclerosis clinics, Neurology, 41, 1193, 10.1212/WNL.41.8.1193 Sadovnick, 1996, Depression and multiple sclerosis, Neurology, 46, 628, 10.1212/WNL.46.3.628 Safarinejad, 2009, Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study, J Urol, 181, 252, 10.1016/j.juro.2008.09.003 Sakurai, 1999, Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine, J Neurol Sci, 162, 162, 10.1016/S0022-510X(98)00322-0 Samkoff, 1997, Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin, Neurology, 49, 304, 10.1212/WNL.49.1.304 Sanchez, 2008, Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis, Eur J Neurol, 15, 1091, 10.1111/j.1468-1331.2008.02259.x Santa Maria, 2004, Functional imaging during covert auditory attention in multiple sclerosis, J Neurol Sci, 218, 9, 10.1016/j.jns.2003.10.019 Sastre-Garriga, 2011, THC and CBD oromucosal spray (Sativex(R)) in the management of spasticity associated with multiple sclerosis, Expert Rev Neurother, 11, 627, 10.1586/ern.11.47 Schiffer, 1990, Antidepressant pharmacotherapy of depression associated with multiple sclerosis, Am J Psychiatry, 147, 1493, 10.1176/ajp.147.11.1493 Schiffer, 1985, Treatment of pathologic laughing and weeping with amitriptyline, N Engl J Med, 312, 1480, 10.1056/NEJM198506063122303 Schiffer, 1986, Association between bipolar affective disorder and multiple sclerosis, Am J Psychiatry, 143, 94, 10.1176/ajp.143.1.94 Schon, 1999, Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis, Neurology, 53, 2209, 10.1212/WNL.53.9.2209-a Schubert, 1993, Increased depression in multiple sclerosis patients A meta-analysis, Psychosomatics, 34, 124, 10.1016/S0033-3182(93)71902-7 Schuele, 2005, Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen, Neurology, 64, 1086, 10.1212/01.WNL.0000154639.35941.21 Schulder, 2003, Thalamic stimulation in patients with multiple sclerosis: long-term follow-up, Stereotact Funct Neurosurg, 80, 48, 10.1159/000075160 Schuurman, 2000, A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor, N Engl J Med, 342, 461, 10.1056/NEJM200002173420703 Schuurman, 2008, Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression, Mov Disord, 23, 1146, 10.1002/mds.22059 Schwid, 2003, A randomized controlled study of the acute and chronic effects of cooling therapy for MS, Neurology, 60, 1955, 10.1212/01.WNL.0000070183.30517.2F Schwid, 2007, Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial, J Neurol Sci, 255, 57, 10.1016/j.jns.2007.01.070 Scott, 1995, Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale, Neurol Res, 17, 421, 10.1080/01616412.1995.11740355 Sechi, 1989, Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up, Neurology, 39, 1113, 10.1212/WNL.39.8.1113 Seliger, 1992, Fluoxetine improves emotional incontinence, Brain Inj, 6, 267, 10.3109/02699059209029668 Serpell, 2013, Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis, J Neurol, 260, 285, 10.1007/s00415-012-6634-z Shafey, 1992, The effect of fluoxetine in depression associated with multiple sclerosis, Can J Psychiatry, 37, 147, 10.1177/070674379203700222 Shaikh, 2011, Pharmacological tests of hypotheses for acquired pendular nystagmus, Ann N Y Acad Sci, 1233, 320, 10.1111/j.1749-6632.2011.06118.x Shakespeare, 2003, Anti-spasticity agents for multiple sclerosis, Cochrane Database Syst Rev, 10.1002/14651858.CD001332 Shaygannejad, 2008, Effects of rivastigmine on memory and cognition in multiple sclerosis, Can J Neurol Sci, 35, 476, 10.1017/S0317167100009148 Shaygannejad, 2012, Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study, Neurol Res, 34, 854, 10.1179/1743132812Y.0000000081 Sheean, 1998, An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis, Brain, 121, 967, 10.1093/brain/121.5.967 Shellenberger, 1999, A controlled pharmacokinetic evaluation of tizanidine and baclofen at steady state, Drug Metab Dispos, 27, 201 Shery, 2006, The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study, Br J Ophthalmol, 90, 839, 10.1136/bjo.2005.086322 Shindel, 2009, 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME), J Sex Med, 6, 1794, 10.1111/j.1743-6109.2009.01347.x Shindel, 2009, 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class, J Sex Med, 6, 2352, 10.1111/j.1743-6109.2009.01447.x Silva, 2005, Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial, Eur Urol, 48, 650, 10.1016/j.eururo.2005.04.012 Sindrup, 2002, Pharmacotherapy of trigeminal neuralgia, Clin J Pain, 18, 22, 10.1097/00002508-200201000-00004 Smith, 2007, Dysarthria predicts poorer performance on cognitive tasks requiring a speeded oral response in an MS population, J Clin Exp Neuropsychol, 29, 804, 10.1080/13803390601064493 Smith, 1999, The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease, Philos Trans R Soc Lond B Biol Sci, 354, 1649, 10.1098/rstb.1999.0510 Smith, 1991, High-dose oral baclofen: experience in patients with multiple sclerosis, Neurology, 41, 1829, 10.1212/WNL.41.11.1829 Smith, 1994, Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial US Tizanidine Study Group, Neurology, 44, 34 Smith, 2000, Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension, Brain, 123, 171, 10.1093/brain/123.1.171 Smith, 2009, fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis, J Neurol Sci, 281, 58, 10.1016/j.jns.2009.02.366 Snow, 1990, Treatment of spasticity with botulinum toxin: a double-blind study, Ann Neurol, 28, 512, 10.1002/ana.410280407 Solari, 2004, Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial, J Neurol Sci, 222, 99, 10.1016/j.jns.2004.04.027 Solaro, 2004, Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study, J Neurol Neurosurg Psychiatry, 75, 341 Solaro, 2011, Management of pain in multiple sclerosis: a pharmacological approach, Nat Rev Neurol, 7, 519, 10.1038/nrneurol.2011.120 Solaro, 1998, An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients, Neurology, 51, 609, 10.1212/WNL.51.2.609 Solaro, 2000, Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis, Eur Neurol, 44, 45, 10.1159/000008192 Solaro, 2004, The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study, Neurology, 63, 919, 10.1212/01.WNL.0000137047.85868.D6 Sommer, 2001, Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function, J Urol, 165, 1181, 10.1016/S0022-5347(05)66461-0 Sperling, 2001, Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study, Arch Neurol, 58, 115, 10.1001/archneur.58.1.115 Sprenger, 2005, Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus, Ann N Y Acad Sci, 1039, 395, 10.1196/annals.1325.037 Sprenger, 2006, Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine, Neurology, 67, 905, 10.1212/01.wnl.0000233829.76150.6b St John, 2006, The use of urinary dipstick tests to exclude urinary tract infection: a systematic review of the literature, Am J Clin Pathol, 126, 428, 10.1309/C69RW1BT7E4QAFPV Staffen, 2002, Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task, Brain, 125, 1275, 10.1093/brain/awf125 Staffen, 2005, Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis, J Neuropsychiatry Clin Neurosci, 17, 357, 10.1176/appi.neuropsych.17.3.357 Stahl, 1996, A pilot study of gabapentin as treatment for acquired nystagmus, Neuroophthalmology, 16, 107, 10.3109/01658109609009669 Stankoff, 2005, Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study, Neurology, 64, 1139, 10.1212/01.WNL.0000158272.27070.6A Starck, 1997, Drug therapy for acquired pendular nystagmus in multiple sclerosis, J Neurol, 244, 9, 10.1007/PL00007728 Starck, 2010, Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin, J Neurol, 257, 322, 10.1007/s00415-009-5309-x Stenager, 1991, Acute and chronic pain syndromes in multiple sclerosis, Acta Neurol Scand, 84, 197, 10.1111/j.1600-0404.1991.tb04937.x Stenager, 1995, Acute and chronic pain syndromes in multiple sclerosis A 5-year follow-up study, Ital J Neurol Sci, 16, 629, 10.1007/BF02230913 Stenager, 1996, Sexual function in multiple sclerosis A 5-year follow-up study, Ital J Neurol Sci, 17, 67, 10.1007/BF01995711 Stone, 1990, Visual responses of Purkinje cells in the cerebellar flocculus during smooth-pursuit eye movements in monkeys II Complex spikes, J Neurophysiol, 63, 1262, 10.1152/jn.1990.63.5.1262 Straube, 2004, EFNS task force – therapy of nystagmus and oscillopsia, Eur J Neurol, 11, 83, 10.1046/j.1468-1331.2003.00754.x Strober, 2009, Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS, Mult Scler, 15, 1077, 10.1177/1352458509106615 Stroud, 2009, The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis, Health Qual Life Outcomes, 7, 68, 10.1186/1477-7525-7-68 Strupp, 2003, Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study, Neurology, 61, 165, 10.1212/01.WNL.0000078893.41040.56 Strupp, 2008, Aminopyridines for the treatment of cerebellar and ocular motor disorders, Prog Brain Res, 171, 535, 10.1016/S0079-6123(08)00676-6 Summers, 2008, Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier, Mult Scler, 14, 197, 10.1177/1352458507082353 Summers, 2008, Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease, J Neurol Neurosurg Psychiatry, 79, 955, 10.1136/jnnp.2007.138685 Svendsen, 2003, Pain in patients with multiple sclerosis: a population-based study, Arch Neurol, 60, 1089, 10.1001/archneur.60.8.1089 Svendsen, 2004, Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial, BMJ, 329, 253, 10.1136/bmj.38149.566979.AE Sweet, 2004, Functional magnetic resonance imaging of working memory among multiple sclerosis patients, J Neuroimaging, 14, 150, 10.1177/1051228403262695 Sweet, 2006, Functional magnetic resonance imaging response to increased verbal working memory demands among patients with multiple sclerosis, Hum Brain Mapp, 27, 28, 10.1002/hbm.20163 Swirsky-Sacchetti, 1992, Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis, Neurology, 42, 1291, 10.1212/WNL.42.7.1291 Tan, 2008, Surgical strategies for faecal incontinence–a decision analysis between dynamic graciloplasty, artificial bowel sphincter and end stoma, Colorectal Dis, 10, 577, 10.1111/j.1463-1318.2007.01418.x Taylor, 1999, Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking, Arch Phys Med Rehabil, 80, 1577, 10.1016/S0003-9993(99)90333-7 Teloken, 1998, Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction, J Urol, 159, 122, 10.1016/S0022-5347(01)64032-1 Tepavcevic, 2008, The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis, Mult Scler, 14, 1131, 10.1177/1352458508093619 Terra, 2006, Electrical stimulation and pelvic floor muscle training with biofeedback in patients with fecal incontinence: a cohort study of 281 patients, Dis Colon Rectum, 49, 1149, 10.1007/s10350-006-0569-3 Terrence, 1981, Complications of baclofen withdrawal, Arch Neurol, 38, 588, 10.1001/archneur.1981.00510090082011 Terrence, 1983, Baclofen Its effect on seizure frequency, Arch Neurol, 40, 28, 10.1001/archneur.1983.04050010048011 Tesar, 2005, Efficacy of a neuropsychological training programme for patients with multiple sclerosis – a randomised controlled trial, Wien Klin Wochenschr, 117, 747, 10.1007/s00508-005-0470-4 The Canadian MS Research Group, 1987, A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis, Can J Neurol Sci, 14, 273, 10.1017/S0317167100026603 Thomas, 2006, Psychological interventions for multiple sclerosis, Cochrane Database Syst Rev, 10.1002/14651858.CD004431.pub2 Thompson, 2005, Clinical management of spasticity, J Neurol Neurosurg Psychiatry, 76, 459, 10.1136/jnnp.2004.035972 Thurtell, 2010, Crossover trial of gabapentin and memantine as treatment for acquired nystagmus, Ann Neurol, 67, 676 Tiemann, 2009, Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns, Mult Scler, 15, 1164, 10.1177/1352458509106853 Tomsak, 1995, Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin, Am J Ophthalmol, 119, 489, 10.1016/S0002-9394(14)71236-X Traccis, 1990, Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms, Neurology, 40, 492, 10.1212/WNL.40.3_Part_1.492 Truini, 2013, A mechanism-based classification of pain in multiple sclerosis, J Neurol, 260, 351, 10.1007/s00415-012-6579-2 Truini, 2012, Mechanisms of pain in multiple sclerosis: A combined clinical and neurophysiological study, Pain, 153, 2048, 10.1016/j.pain.2012.05.024 Turner-Stokes, 2002, Botulinum toxin in the management of spasticity in adults, Clin Med, 2, 128, 10.7861/clinmedicine.2-2-128 Tzortzis, 2008, Sexual dysfunction in newly diagnosed multiple sclerosis women, Mult Scler, 14, 561, 10.1177/13524585080140040901 Udaka, 1984, Pathologic laughing and crying treated with levodopa, Arch Neurol, 41, 1095, 10.1001/archneur.1984.04050210093023 United Kingdom Tizanidine Trial Group, 1994, A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis, Neurology, 44, 70 Vacca, 2007, Multiple sclerosis and headache co-morbidity. A case-control study, Neurol Sci, 28, 133, 10.1007/s10072-007-0805-1 Vahtera, 1997, Pelvic floor rehabilitation is effective in patients with multiple sclerosis, Clin Rehabil, 11, 211, 10.1177/026921559701100304 Vakhapova, 2010, Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety, Clin Neuropharmacol, 33, 151, 10.1097/WNF.0b013e3181daad7d Valiquette, 1996, Desmopressin in the management of nocturia in patients with multiple sclerosis A double-blind, crossover trial, Arch Neurol, 53, 1270, 10.1001/archneur.1996.00550120082020 Van Der Walt, 2012, A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor, Neurology, 79, 92, 10.1212/WNL.0b013e31825dcdd9 van Diemen, 1992, The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study, Ann Neurol, 32, 123, 10.1002/ana.410320203 Vender, 2006, Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients, J Neurosurg, 104, 9 Vender, 2006, Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction, Neurosurg Focus, 21, e6, 10.3171/foc.2006.21.2.7 Vermote, 1986, Pain in multiple sclerosis patients A prospective study using the Mc Gill Pain Questionnaire, Clin Neurol Neurosurg, 88, 87, 10.1016/S0303-8467(86)80002-6 Villoslada, 2009, Memantine induces reversible neurologic impairment in patients with MS, Neurology, 72, 1630, 10.1212/01.wnl.0000342388.73185.80 Vleugels, 2000, Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks, Mult Scler, 6, 241, 10.1177/135245850000600406 Von Keitz, 2002, A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction, BJU Int, 89, 409, 10.1046/j.1464-4096.2001.01453.x Voss, 2002, Contributing factors to depressed mood in Multiple Sclerosis, Arch Clin Neuropsychol, 17, 103, 10.1093/arclin/17.2.103 Wade, 2003, A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms, Clin Rehabil, 17, 21, 10.1191/0269215503cr581oa Wade, 2004, Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients, Mult Scler, 10, 434, 10.1191/1352458504ms1082oa Wagstaff, 1997, Tizanidine A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders, Drugs, 53, 435, 10.2165/00003495-199753030-00007 Waldron, 1993, Multiple sclerosis: assessment of colonic and anorectal function in the presence of faecal incontinence, Int J Colorectal Dis, 8, 220, 10.1007/BF00290311 Wallace, 1994, Summary of combined clinical analysis of controlled clinical trials with tizanidine, Neurology, 44, S60 Wallace, 2007, Sacral nerve neuromodulation in patients with underlying neurologic disease, Am J Obstet Gynecol, 197, 96 Walter, 2006, Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia, Nat Neurosci, 9, 389, 10.1038/nn1648 Wang, 2007, Combining recessions (nystagmus and strabismus) with tenotomy improved visual function and decreased oscillopsia and diplopia in acquired downbeat nystagmus and in horizontal infantile nystagmus syndrome, J AAPOS, 11, 135, 10.1016/j.jaapos.2006.10.012 Ward, 2008, Spasticity treatment with botulinum toxins, J Neural Transm, 115, 607, 10.1007/s00702-007-0833-2 Warke, 2006, Efficacy of transcutaneous electrical nerve stimulation (tens) for chronic low-back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial, Clin J Pain, 22, 812, 10.1097/01.ajp.0000210935.73686.79 Weber, 1987, Radiopaque markers transit and anorectal manometry in 16 patients with multiple sclerosis and urinary bladder dysfunction, Dis Colon Rectum, 30, 95, 10.1007/BF02554940 Weinshenker, 1992, A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis, Neurology, 42, 1468, 10.1212/WNL.42.8.1468 Weinstein, 1999, Neuropsychologic status in multiple sclerosis after treatment with glatiramer, Arch Neurol, 56, 319, 10.1001/archneur.56.3.319 White, 2000, Effect of precooling on physical performance in multiple sclerosis, Mult Scler, 6, 176, 10.1177/135245850000600307 Wiesel, 2000, Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis, J Neurol Neurosurg Psychiatry, 69, 240, 10.1136/jnnp.69.2.240 Wiesel, 2001, Pathophysiology and management of bowel dysfunction in multiple sclerosis, Eur J Gastroenterol Hepatol, 13, 441, 10.1097/00042737-200104000-00025 Wilken, 2007, Recognizing and treating common psychiatric disorders in multiple sclerosis, Neurologist, 13, 343, 10.1097/NRL.0b013e31806dc2e8 Wishart, 2003, Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports, J Neurol Neurosurg Psychiatry, 74, 1392, 10.1136/jnnp.74.10.1392 Wishart, 2004, Brain activation patterns associated with working memory in relapsing-remitting MS, Neurology, 62, 234, 10.1212/01.WNL.0000103238.91536.5F Wissel, 2006, Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain: a double-blind placebo-controlled cross-over trial, J Neurol, 253, 1337, 10.1007/s00415-006-0218-8 Wood, 2013, Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis, Mult Scler, 19, 217, 10.1177/1352458512450351 Ybarra, 2007, Bipolar disorder and multiple sclerosis, Arq Neuropsiquiatr, 65, 1177, 10.1590/S0004-282X2007000700016 Zaaraoui, 2011, Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration, J Neurol, 258, 811, 10.1007/s00415-010-5845-4 Zahariou, 2008, Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia, Int Urol Nephrol, 40, 65, 10.1007/s11255-007-9232-8 Zahavi, 2004, Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin, J Neurol Neurosurg Psychiatry, 75, 1553, 10.1136/jnnp.2003.014282 Zajicek, 2003, Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial, Lancet, 362, 1517, 10.1016/S0140-6736(03)14738-1 Zajicek, 2005, Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up, J Neurol Neurosurg Psychiatry, 76, 1664, 10.1136/jnnp.2005.070136 Zajicek, 2012, MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial, J Neurol Neurosurg Psychiatry, 83, 1125, 10.1136/jnnp-2012-302468 Zakrzewska, 2009, Trigeminal neuralgia, Clin Evid (Online) Zakrzewska, 1997, Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial, Pain, 73, 223, 10.1016/S0304-3959(97)00104-8 Zephir, 2005, One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis, Mult Scler, 11, 360, 10.1191/1352458505ms1172sr Ziemssen, 2008, Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis, Health Qual Life Outcomes, 6, 67, 10.1186/1477-7525-6-67 Ziemssen, 2011, Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis, Altern Ther Health Med, 17, 22 Zifko, 2004, Management of fatigue in patients with multiple sclerosis, Drugs, 64, 1295, 10.2165/00003495-200464120-00003 Zifko, 2002, Modafinil in treatment of fatigue in multiple sclerosis Results of an open-label study, J Neurol, 249, 983, 10.1007/s00415-002-0765-6 Zivadinov, 1999, Sexual dysfunction in multiple sclerosis: II Correlation analysis, Mult Scler, 5, 428 Zorro, 2009, Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia, Neurology, 73, 1149, 10.1212/WNL.0b013e3181bacfb4 Zorzon, 1999, Sexual dysfunction in multiple sclerosis: a case-control study I Frequency and comparison of groups, Mult Scler, 5, 418 Zorzon, 2001, Depression and anxiety in multiple sclerosis A clinical and MRI study in 95 subjects, J Neurol, 248, 416, 10.1007/s004150170184 Zvartau-Hind, 2000, Topiramate relieves refractory trigeminal neuralgia in MS patients, Neurology, 55, 1587, 10.1212/WNL.55.10.1587